跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
在 國立陽明交通大學研發優勢分析平台 搜尋內容
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple Targets
Pei Chen Yu
, Chen Hao Huang
, Chih Jung Kuo
, Po Huang Liang
, Lily Hui Ching Wang
, Max Yu Chen Pan
, Sui Yuan Chang
, Tai Ling Chao
, Si Man Ieong
, Jun Tung Fang
,
Hsuan Cheng Huang
*
, Hsueh Fen Juan
*
*
此作品的通信作者
生物醫學資訊研究所
研究成果
:
Article
›
同行評審
7
引文 斯高帕斯(Scopus)
總覽
指紋
指紋
深入研究「Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple Targets」主題。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Multi-target
100%
Drug Repurposing
100%
COVID-19
100%
Drug Screening
40%
Therapeutic Potential
20%
Bioinformatics
20%
Vaccine Development
20%
Inhibitory Effect
20%
Enzyme Activity
20%
3C-like Protease (3CLpro)
20%
Protease
20%
Savings Method
20%
Feasible Strategy
20%
U.S. Food
20%
Inhibitory Performance
20%
Papain-like
20%
Multiplex Assay
20%
Transmembrane Protease Serine 2 (TMPRSS2)
20%
Plaque Reduction Assay
20%
Antiviral Potency
20%
Spike Receptor Binding Domain
20%
Pharmacology, Toxicology and Pharmaceutical Science
Drug Repositioning
100%
SARS Coronavirus
100%
Diseases
100%
Proteinase
66%
Coronavirinae
66%
Drug Screening
33%
Infection
33%
Receptor
33%
Serine Proteinase
33%
Antivirus Agent
33%
Tamoxifen
33%
Papain
33%
Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Drug Repositioning
100%
Proteinase
66%
COVID-19
66%
Drug Screening
33%
Infection
33%
Serine Proteinase
33%
Receptor Binding
33%
Enzyme Activity
33%
Antivirus Agent
33%
Tamoxifen
33%
Papain
33%
Diseases
33%